These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 4052983)

  • 1. Deletions of chromosome 13 in malignant hematologic disorders.
    Johnson DD; Dewald GW; Pierre RV; Letendre L; Silverstein MN
    Cancer Genet Cytogenet; 1985 Nov; 18(3):235-41. PubMed ID: 4052983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hematologic manifestations associated with deletions of the long arm of chromosome 20.
    Davis MP; Dewald GW; Pierre RV; Hoagland HC
    Cancer Genet Cytogenet; 1984 May; 12(1):63-71. PubMed ID: 6713360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deletion (11)(q13) as the sole anomaly in myeloid malignancies: four new cases and a short review.
    Panani AD; Pappa V; Papageorgiou S; Stamatelli F; Raptis SA
    Ann Hematol; 2004 Mar; 83(3):153-5. PubMed ID: 15064863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deletion of chromosome band 13q14: a primary event in preleukemia and leukemia.
    Morgan R; Hecht F
    Cancer Genet Cytogenet; 1985 Nov; 18(3):243-9. PubMed ID: 4052984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interstitial 9q- deletions in hematologic malignancies.
    Mecucci C; Vermaelen K; Kulling G; Michaux JL; Noens L; Van Hove W; Tricot G; Louwagie A; Van den Berghe H
    Cancer Genet Cytogenet; 1984 Aug; 12(4):309-19. PubMed ID: 6744226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular characterization of chromosome 7 long arm deletions in myeloid disorders.
    Kere J; Ruutu T; Lahtinen R; de la Chapelle A
    Blood; 1987 Nov; 70(5):1349-53. PubMed ID: 2889483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consistent interstitial chromosomal deletions in myeloid malignancies and their correlation with fragile sites.
    Hirst WJ; Czepulkowski B; Mufti GJ
    Cancer Genet Cytogenet; 1993 Jan; 65(1):51-7. PubMed ID: 8431916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromosome studies in 104 patients with polycythemia vera.
    Diez-Martin JL; Graham DL; Petitt RM; Dewald GW
    Mayo Clin Proc; 1991 Mar; 66(3):287-99. PubMed ID: 2002687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular genetic evidence of Y chromosome loss in male patients with hematological disorders.
    Zhang LJ; Shin ES; Yu ZX; Li SB
    Chin Med J (Engl); 2007 Nov; 120(22):2002-5. PubMed ID: 18067786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 6p+ and 9q- in two chromosomally distinct clones occurring in a case of myelodysplastic syndrome evolving to acute nonlymphocytic leukemia.
    Ringressi A; Mecucci C; Grossi A; Bernabei PA; Ferrini PR; Van den Berghe H
    Cancer Genet Cytogenet; 1988 Oct; 35(2):213-21. PubMed ID: 3052797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromosome abnormalities involving band 13q14 in hematologic malignancies.
    Fitchett M; Griffiths MJ; Oscier DG; Johnson S; Seabright M
    Cancer Genet Cytogenet; 1987 Jan; 24(1):143-50. PubMed ID: 3491671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hematologic disorders associated with deletions of chromosome 20q: a clinicopathologic study of 107 patients.
    Kurtin PJ; Dewald GW; Shields DJ; Hanson CA
    Am J Clin Pathol; 1996 Nov; 106(5):680-8. PubMed ID: 8929482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 5q-anomaly.
    Van den Berghe H; Vermaelen K; Mecucci C; Barbieri D; Tricot G
    Cancer Genet Cytogenet; 1985 Jul; 17(3):189-255. PubMed ID: 3891074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Translocation (1;7)(p11;p11): a new myeloproliferative hematologic entity.
    Sandberg AA; Morgan R; Hecht BK; Hecht F
    Cancer Genet Cytogenet; 1985 Nov; 18(3):199-206. PubMed ID: 4052981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Translocations involving chromosomes #3 and #12: hematologic diseases associated with abnormalities of these chromosomes.
    Sandberg AA; Hecht BK; Ondreyco SM; Prieto F; Hecht F
    Cancer Genet Cytogenet; 1982 Sep; 7(1):1-17. PubMed ID: 6754070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Derivative (1;18)(q10;q10): a recurrent and novel unbalanced translocation involving 1q in myeloid disorders.
    Wan TS; Ma SK; Au WY; Chan LC
    Cancer Genet Cytogenet; 2001 Jul; 128(1):35-8. PubMed ID: 11454427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trisomy 9 in hematologic disorders: possible association with primary thrombocytosis.
    Cournoyer D; Noël P; Schmidt MA; Dewald GW
    Cancer Genet Cytogenet; 1987 Jul; 27(1):73-8. PubMed ID: 3472649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytogenetic deletion maps of hematologic neoplasms: circumstantial evidence for tumor suppressor loci.
    Johansson B; Mertens F; Mitelman F
    Genes Chromosomes Cancer; 1993 Dec; 8(4):205-18. PubMed ID: 7512363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of del(20q) in patients with hematological malignancies.
    Brezinová J; Zemanová Z; Ransdorfová S; Sindelárová L; Sisková M; Neuwirtová R; Cermák J; Michalová K
    Cancer Genet Cytogenet; 2005 Jul; 160(2):188-92. PubMed ID: 15993278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cytogenetic studies in hematological diseases. Analysis of 185 cases].
    Porto B; Mota A; Coutinho J; Justiça B; Malheiro MI
    Sangre (Barc); 1993 Apr; 38(2):103-14. PubMed ID: 8516724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.